<span class=

doi:10.3760/cma.j.cn115909-20210214-00059

摘要
图/表
参考文献(51)
相关文章 (15)

全文: PDF 671KB HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

文章导读

摘要近年来，近视呈现高发、低龄的趋势。近视不仅影响视力，还可引起玻璃体及眼底的退行性病变，高度近视相关并发症更是导致低视力和盲的重要病因。角膜塑形镜作为目前控制近视进展的重要方法也成为了一大热点。如今国内外关于角膜塑形镜控制近视进展的研究较多，现笔者针对近视流行及角膜塑形镜控制近视的有效性和安全性等方面作一综述。

	服务

	把本文推荐给朋友角膜塑形镜控制近视进展的研究现状 ”的文章，特向您推荐。请打开下面的网址：https://www.cjoovs.com/CN/abstract/abstract2317.shtml" name="neirong">
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：近视, 角膜塑形镜, 有效性, 安全性

Abstract：In recent years, the prevalence of myopia is increasing and there's a trend towards patients becoming myopic at an earlier age. Myopia can not only affect distant vision, but also cause degeneration of vitreous body and fundus. High myopia related complications are important factors leading to low vision and blindness. Orthokeratology as an important method to control myopia progression has become a hot spot. At present, there are many studies on the progress of orthokeratology in controlling myopia at home and abroad. This review focuses on the prevalence of myopia and the effectiveness and safety of orthokeratology in controlling myopia.

Key words： myopia orthokeratology effectiveness safety

收稿日期: 2021-02-14

PACS:

基金资助:国家自然科学基金（ 81900840）

通讯作者: 倪海龙（ ORCID： 0000-0002-2259-9873）， Email： 2101092@zju.edu.cn

引用本文:

褚梦琪赵莹莹吴志毅倪海龙鱼音慧. 角膜塑形镜控制近视进展的研究现状
[J]. 中华眼视光学与视觉科学杂志, 2021, 23(10): 791-795. Mengqi Chu, Yingying Zhao, Zhiyi Wu, Hailong Ni, Yinhui Yu. Current Situation of Orthokeratology in Myopia Control
. Chinese Journal of Optometry Ophthalmology and Visual science, 2021, 23(10): 791-795. DOI: 10.3760/cma.j.cn115909-20210214-00059

链接本文:

https://www.cjoovs.com/CN/10.3760/cma.j.cn115909-20210214-00059 或 https://www.cjoovs.com/CN/Y2021/V23/I10/791

[1]	Cooper J, Tkatchenko AV. A Review of current concepts of the etiology and treatment of myopia. Eye Contact Lens, 2018, 44(4): 231-247. DOI: 10.1097/ICL.0000000000000499.
[2]	Hoogerheide J, Rempt F, Hoogenboom WP. Acquired myopia in young pilots. Ophthalmologica, 1971, 163(4): 209-215. DOI: 10.1159/000306646.
[3]	Rempt F, Hoogerheide J, Hoogenboom WP. Peripheral retinoscopy and the skiagram. Ophthalmologica, 1971, 162(1): 1-10. DOI:10.1159/000306229.
[4]	Hao Wu, Wei Chen, Fei Zhao, et al. Scleral hypoxia is a target for myopia control. Proc Natl Acad Sci USA, 2018, 115(30): E7091-E7100. DOI: 10.1073/pnas.1721443115.
[5]	Mariana B, Amit K, Kevin E, et al. A bioengineering approach to myopia control tested in a guinea pig model. Invest Ophthalmol Vis Sci, 2017, 58(3): 1875-1886. DOI: 10.1167/iovs.16-20694.
[6]	Zhang HY, Lam CSY, Tang WC, et al. Defocus incorporated multiple segments spectacle lenses changed the relative peripheral refraction: A 2-year randomized clinical trial. Invest Ophthalmol Vis Sci, 2020, 61(5): 53. DOI: 10.1167/ iovs.61.5.53.
[7]	Cheng D, Woo GC, Drobe B, et al. Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial. JAMA Ophthalmol, 2014, 132(3): 258-264. DOI: 10.1001/ jamaophthalmol.2013.7623.
[8]	LI Y, Fu Y, Wang K, et al. Evaluating the myopia progression control efficacy of defocus incorporated multiple segments (DIMS) lenses and Apollo progressive addition spectacle lenses (PALs) in 6- to 12-year-old children: study protocol for a prospective, multicenter, randomized controlled trial. Trials, 2020, 21(1): 279. DOI: 10.1186/s13063-020-4095-8.
[9]	Cooper J, O'Connor B, Watanabe R, et al. Case series analysis of myopic progression control with a unique extended depth of focus multifocal contact lens. Eye Contact Lens, 2018 , 44(5): e16-e24. DOI: 10.1097/ICL.0000000000000440.
[10]	Wu PC, Chuang MN, Choi J, et al. Update in myopia and treatment strategy of atropine use in myopia control. Eye (Lond), 2019, 33(1): 3-13. DOI: 10.1038/s41433-018-0139-7.
[11]	Yam JC, Jiang Y, Tang SM, et al. Low-concentration atropine for myopia progression (LAMP) study: A randomized, double blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology, 2019,126(1): 113-124. DOI: 10.1016/j.ophtha.2018.05.029.
[12]	Singh K, Bhattacharyya M, Goel A, et al. Orthokeratology in moderate myopia: A study of predictability and safety. JOphthalmic Vis Res, 2020, 15(2): 210-217. DOI:10.18502/jovr.v15i2.6739.
[13]	Tan Q, Ng AL, Cheng GP, et al. Combined atropine withorthokeratology for myopia control: Study design and preliminary results. Curr Eye Res, 2019, 44(6): 671-678. DOI:10.1080/02713683.2019.1568501.
[14]	Christos T, Bobeck S, Michael B, et al. Myopia prevalence and risk factors in children. Clin Ophthalmol, 2018, 12: 1581-1587. DOI: 10.2147/OPTH.S164641.
[15]	Yang L, Vass C, Smith L, et al. Thirty-five-year trend in the prevalence of refractive error in Austrian conscripts based on 1.5 million participants. Br J Ophthalmol, 2020, 104(10): 1338-1344. DOI: 10.1136/bjophthalmol-2019-315024.
[16]	French AN, Morgan IG, Burlutsky G, et al. Prevalence and 5- to 6-year incidence and progression of myopia and hyperopia in Australian school children. Ophthalmology, 2013, 120(7): 1482-1491. DOI: 10.1016/j.ophtha.2012.12.018.
[17]	Chen M, Wu A, Zhang L, et al. The increasing prevalence of myopia and high myopia among high school students in Fenghua city, eastern China: A 15-year population-based survey. BMC Ophthalmol, 2018, 181(1): 159. DOI: 10.1186/s12886-018-0829-8.
[18]	Emi U, Miho Y, Kohta F, et al. Trends in the prevalence of myopia and myopic maculopathy in a Japanese population: The hisayama study. Invest Ophthalmol Vis Sci,2019, 60(8): 2781-2786. DOI: 10.1167/iovs.19-26580.
[19]	Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt, 2012, 32(1):3-16. DOI: 10.1111/j.1475-1313.2011.00884.x.
[20]	Pauline Cho, Qi Tan. Myopia and orthokeratology for myopia control. Clin Exp Optom, 2019, 102(4): 364-377. DOI: 10.1111/cxo.12839.
[21]	Pan CW, Wu RK, Li J, et al. Low prevalence of myopia among school children in rural China. BMC Ophthalmol, 2018, 18(1):140. DOI: 10.1186/s12886-018-0808-0.
[22]	Wang SK, Guo Y, Liao C, et al. Incidence of and factors associated with myopia and high myopia in Chinese children, based on refraction without cycloplegia. JAMA
	Ophthalmol, 2018, 136(9): 1017-1024. DOI: 10.1001/jamaophthalmol.2018.2658.
[23]	Chua SY, Sabanayagam C, Cheung YB, et al. Age of onset of myopia predicts risk of high myopia in later childhood in myopic Singapore children. Ophthalmic Physiol Opt, 2016,36(4): 388-394. DOI: 10.1111/opo.12305.
[24]	Wen G, Tarczy-Hornoch K, McKean-Cowdin R, et al. Multiethnic pediatric eye disease study group; prevalence of myopia, hyperopia, and astigmatism in non-Hispanic white and Asian children: Multi-ethnic pediatric eye disease study. Ophthalmology, 2013, 120(10): 2109-2116. DOI: 10.1016/j.ophtha.2013.06.039.
[25]	Sara J McCullough, Lisa O'Donoghue, Kathryn J Saunders.Six Year Refractive Change among White Children and Young Adults: Evidence for Significant Increase in Myopia among White UK Children. PLoS One, 2016, 11(1): e0146332. DOI: 10.1371/journal.pone.0146332.
[26]	Sorsby A, Benjamin B, Sheridan M, et al. Refraction and its components during the growth of the eye from age of three. Memo Med Res Counc,1961, 301(special): 1-67.
[27]	Dirani M, Chan YH, Gazzard G, et al. Prevalence of refractive error in Singaporean Chinese children: The strabismus, amblyopia, and refractive error in young Singaporean children (STARS) study. Invest Ophthalmol Vis Sci, 2010, 51: 1348- 1355. DOI: 10.1167/iovs.09-3587.
[28]	Lam CS, Lam CH, Cheng SC, et al. Prevalence of myopia among Hong Kong Chinese schoolchildren: Changes over two decades. Ophthalmic Physiol Opt, 2012, 32(1): 17-24. DOI: 10.1111/j.1475-1313.2011.00886.x.
[29]	Rim TH, Kim SH, Lim KH, et al. Refractive errors in Koreans: The Korea National Health and nutrition examination survey 2008-2012. Korean J Ophthalmol, 2016, 30(3): 214-224. DOI: 10.1080/02713683.2018.1472286.
[30]	Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology, 2016, 123(5): 1036-1042. DOI: 10.1136/ bjophthalmol-2017-311266.
[31]	Harper Ar, Sum M, Ers Ja. The dynamic sclera: Extracellular matrix remodeling in normal ocular growth and myopia development. Exp Eye Res, 2015, 133: 100-111. DOI: 10.1016/ j.exer.2014.07.015.
[32]	Koh V, Tan C, Tan PT, et al. Myopic maculopathy and optic disc changes in highly myopic young Asian eyes and impact on visual acuity. Am J Ophthalmol, 2016, 164: 69-79. DOI: 10.1016/j.ajo.2016.04.028.
[33]	Ohno-Matsuik, Laity, Laicc, Cheung Cm. Updates of pathologic myopia. Prog Ret in Eye Res, 2016, 52: 156-187. DOI: 10.1016/ j.preteyeres.2015.12.001.
[34]	艾欣, 张学辉, 叶璐. 角膜塑形镜控制青少年近视有效性及安全性的Meta分析. 中华眼视光学与视觉科学杂志, 2019, 21(2): 127-134. DOI: 10.3760/cma.j.issn.1674-845X.2019.02. 009.
[35]	Lipson MJ, Brooks MM, Koffler BH. The role of orthokeratology in myopia control: A review. Eye Contact Lens, 2018, 44(4): 224-230. DOI: 10.1097/ICL.0000000000000520.
[36]	Cho P, Cheung SW. Retardation of Myopia in Orthokeratology (ROMIO) Study: A 2-year randomized clinical trial. Invest Ophthalmol Vis Sci, 2012, 53(11): 7077-7085. DOI: 10.1167/ iovs.16-20594.
[37]	He M, Du Y, Liu Q, et al. Effects of orthokeratology on the progression of low to moderate myopia in Chinese children. BMC Ophthalmol, 2016, 16: 126. DOI: 10.1186/s12886-016- 0302-5.
[38]	Lyu T, Wang L, Zhou L, et al. Regimen Study of High Myopia Partial Reduction Orthokeratology. Eye Contact Lens, 2020,46(3): 141-146. DOI:10.1097/ICL.0000000000000629.
[39]	Hiraoka T, Kakita T, Okamoto F, et al. Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci, 2012, 53: 3913-3919. DOI: 10.1167/iovs.11-8453.
[40]	Zhu MJ, Feng HY, He XG, et al. The control effect of orthokeratology on axial length elongation in Chinese children with myopia. BMC Ophthalmol, 2014, 14: 141. DOI:10.1186/1471-2415-14-141.
[41]	Yu LH, Jin WQ, Mao XJ, et al. Effect of orthokeratology on axial length elongation in moderate myopic and fellow high myopic eyes of children. Clin Exp Optom, 2021, 104(1): 22-27.DOI: 10.1111/cxo.13067.
[42]	Chen Z, Niu L, Xue F, et al. Impact of pupil diameter on axial growth in orthokeratology. Optom Vis Sci, 2012, 89: 1636-1640.DOI: 10.1097/OPX.0b013e31826c1831.
[43]	符爱存, 吕勇, 姬娜, 等. 角膜塑形镜控制青少年近视进展效果的相关因素. 中华眼视光学与视觉科学杂志, 2016, 18(2):72-77.
	DOI: 10.3760/cma.j.issn.1674845X.2016.02.003.
[44]	Cho P, Cheung SW. Discontinuation of orthokeratology oneyeball elongation (DOEE). Cont Lens Anterior Eye, 2017,40(2): 82-87. DOI: 10.1016/j.clae.2016.12.002.
[45]	Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci2013, 54: 6510-6517. DOI: 10.1167/iovs.13-12527.
[46]	杨丽娜, 郭曦, 谢培英. 角膜塑形镜停戴后屈光状态和角膜形态的观察. 中华眼科杂志, 2015, 51(3): 178-182. DOI: 10.3760/cma.j.issn.0412.4081.2015.03.006.
[47]	COMET Group. Myopia stabilization and associated factors among participants in the Correction of Myopia Evaluation Trial (COMET). Invest Ophthalmol Vis Sci, 2013,54: 7871-7884.DOI: 10.1167/iovs.13-12403.
[48]	Ruiz-Pomeda A, Pérez-Sánchez B, Prieto-Garrido FL, et al.MiSight assessment study Spain: Adverse events, tear film osmolarity, and discontinuations. Eye Contact Lens, 2018, 44(Suppl 2): S180-S186. DOI: 10.1097/ICL.0000000000000484.
[49]	Hu P, Zhao Y, Chen D, et al. The safety of orthokeratology in myopic children and analysis of related factors. Cont Lens Anterior Eye, 2021, 44(1): 89-93. DOI:10.1016/j.clae.2020.08.011.
[50]	Liu YM, Xie P. The safety of orthokeratology-a systematic review. Eye Contact Lens, 2016, 42(1): 35-42. DOI: 10.1097/ICL.0000000000000219.
[51]	Swarbrick HA, Alharbi A, Watt K, et al. Myopia control during orthokeratology lens wear in children using a novel study design. Ophthalmology, 2015, 122: 620-630. DOI: 10.1016/j.ophtha.2014.09.028.